+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Biodegradable Coronary Stents Market by Material (Iron, Magnesium, Polymer), Application (Acute Coronary Syndrome, Stable Angina), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124076
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biodegradable coronary stents have emerged as a transformative intervention in cardiovascular medicine, offering a paradigm shift from permanent metal scaffolds to devices designed to dissolve over time. In recent years, clinical demand for next-generation stent platforms that reduce long-term complications, such as late stent thrombosis and chronic vessel inflammation, has surged dramatically. Consequently, research institutions and medical device manufacturers have intensified efforts to develop materials and design features that balance radial strength, biocompatibility, and controlled degradation rates.

As the global burden of coronary artery disease continues to rise, clinicians and healthcare systems are placing greater emphasis on patient-centric treatment modalities that minimize repeat interventions and long-term pharmacotherapy. Moreover, advancements in imaging techniques and interventional cardiology practices have enhanced the precision of stent implantation, thereby amplifying the clinical value proposition of bioresorbable scaffolds. By addressing both acute procedural success and long-term vessel healing, biodegradable coronary stents are redefining post-intervention care pathways.

Looking ahead, continued innovation in polymer science, metallic alloy engineering, and additive manufacturing is expected to drive the next wave of product enhancements. Enhanced collaboration between regulatory authorities and manufacturers will also streamline pathways for accelerated approvals and market adoption. Collectively, these factors underscore the pivotal role of biodegradable coronary stents in shaping the future of interventional cardiology.

Examining the Paradigm Shift Fueled by Material Innovations Digital Solutions and Regulatory Evolution in Biodegradable Coronary Stent Development

The landscape of biodegradable coronary stents is undergoing rapid transformation driven by breakthroughs in material science, digital integration, and evolving regulatory frameworks. Initially dominated by polymer-based scaffolds, the market has welcomed metallic alloys such as iron and magnesium, which offer improved radial force and more predictable degradation profiles. These material innovations have fostered more durable scaffold platforms while preserving the long-term safety benefits of bioresorbable devices.

Furthermore, the integration of advanced imaging modalities and digital patient monitoring tools has enhanced procedural planning and postoperative surveillance. Real-time vessel assessment technologies are enabling clinicians to make data-driven decisions during implantation, thereby improving patient outcomes. Additionally, the proliferation of digital health ecosystems is facilitating remote monitoring of vascular healing and enabling proactive management of adverse events.

Regulatory bodies are also adapting to the unique characteristics of bioresorbable devices by refining evaluation criteria and post-market surveillance requirements. In parallel, public-private partnerships have accelerated clinical trial programs and fostered knowledge exchange across academic, clinical, and industrial stakeholders. As these synergistic forces continue to converge, the biodegradable coronary stent sector is poised for sustained innovation and broader clinical adoption.

Evaluating the 2025 United States Tariff Framework and Its Cumulative Impact on Supply Chains Manufacturing Costs and Market Accessibility

In 2025, the United States implemented tariffs that have significantly influenced the biodegradation device supply chain from raw material sourcing to final product distribution. Applied primarily to imported alloys and specialty polymers, these tariff measures have elevated manufacturing costs, prompting device makers to reassess supply chain strategies and explore domestic sourcing alternatives. As a result, manufacturers are forging strategic alliances with local suppliers and investing in vertically integrated production facilities to mitigate cost pressures.

Moreover, the cumulative impact of these tariffs has reverberated through pricing negotiations with healthcare providers and reimbursement stakeholders. Hospitals and ambulatory centers are increasingly scrutinizing total cost of ownership and long-term value propositions, which has led to intensified discussions around innovative procurement models. Consequently, some developers are adopting risk-sharing agreements and outcome-based pricing structures to align stakeholder incentives and foster broader access.

Despite these challenges, the tariffs have also catalyzed renewed focus on process optimization and lean manufacturing techniques. By streamlining design workflows and enhancing production efficiencies, companies are offsetting incremental cost increases. Additionally, government incentives for domestic innovation and manufacturing have emerged as a counterbalance, supporting research and development initiatives aimed at next-generation scaffold platforms with optimized supply chains.

Unlocking Critical Market Segmentation Insights Spanning Material Composition Clinical Applications End User Dynamics and Distribution Strategies

Insights into market segmentation reveal critical nuances in material composition, clinical application, end-user preferences, and distribution channels that define strategic priorities. Iron-based scaffolds are gaining traction due to their favorable degradation timelines and mechanical stability, while magnesium alloys are being optimized for rapid resorption and minimal inflammatory response. Polymer formulations, including Pdlla and Plla variants, continue to evolve with enhanced drug-eluting properties and predictable bioresorption kinetics.

In terms of clinical deployment, the use of these devices in acute coronary syndrome settings underscores their capacity to address complex lesion profiles and reduce the incidence of revascularization procedures. Conversely, applications in stable angina benefit from scaffolds that maintain vessel patency during the healing phase and subsequently relinquish permanent implant presence to preserve vascular physiology.

End users are also shaping the competitive landscape. Hospital-owned ambulatory surgical centers leverage integrated care pathways and bulk procurement models to drive procedural volume, while independent ambulatory centers emphasize personalized patient experiences and streamlined operational processes. Within hospital networks, specialized cardiac centers focus on early adoption of cutting-edge technologies, whereas multi-specialty institutions prioritize cost efficiency and cross-departmental utilization. Finally, distribution strategies continue to balance direct tender arrangements that offer price transparency with partnerships through third party distributors that extend market reach and service capabilities.

Mapping Regional Growth Drivers and Adoption Patterns Across Americas Europe Middle East Africa and Asia Pacific Biodegradable Coronary Stent Markets

Regional dynamics illustrate diverse adoption patterns and growth drivers across the Americas, Europe, Middle East and Africa, and Asia-Pacific territories. In the Americas, healthcare infrastructure upgrades and high procedure volumes have catalyzed the adoption of advanced scaffold technologies, complemented by favorable reimbursement environments and robust clinical trial ecosystems. North American hubs, in particular, serve as innovation centers for device refinement and procedural best practices.

Conversely, the Europe, Middle East and Africa region exhibits heterogeneity in regulatory timelines and healthcare funding models. Western European markets benefit from streamlined approval processes and comprehensive post-market surveillance, whereas emerging economies are navigating cost containment measures and expanding access to interventional cardiology services. Collaborative initiatives between government agencies and device manufacturers are driving localized clinical programs to demonstrate long-term clinical value.

Asia-Pacific stands out for its high growth potential, powered by rising procedural volumes, expanding medical infrastructure, and growing awareness of minimally invasive solutions. Strategic partnerships between global device companies and regional distributors are enhancing training programs and post-procedure monitoring. Additionally, domestic research institutions are increasingly participating in scaffold innovation, positioning the region as both a significant consumer and contributor to biodegradable stent advancements.

Profiling Key Industry Players and Analyzing Their Strategic Moves Partnerships Investments and Technological Advances in Biodegradable Coronary Stents

The competitive landscape of biodegradable coronary stents features a mix of established medical device companies and emerging specialized firms, each driving innovation through distinct strategic moves. Leading players have prioritized robust clinical evidence generation, investing heavily in multi-center trials to substantiate the safety and efficacy profiles of next-generation scaffolds. These clinical programs often focus on diverse patient cohorts to address unmet needs across acute coronary syndrome and stable angina populations.

Partnerships and acquisitions have also shaped market dynamics, with major corporations seeking to augment their product portfolios through alliances with technology startups and academic spin-offs. Such collaborations facilitate rapid incorporation of novel biomaterials and surface coatings, while providing access to specialized manufacturing capabilities. Additionally, several companies are exploring digital health integration, embedding sensors and wireless monitoring features into scaffold platforms to enable real-time assessment of vessel healing.

Investment in manufacturing scale-up and supply chain resilience remains a critical area of focus. Organizations are streamlining global production footprints and implementing advanced quality control processes to ensure consistent performance across geographic markets. As these strategic initiatives converge, industry leaders are positioning themselves to deliver differentiated offerings that meet evolving clinical and economic demands.

Outlining Actionable Recommendations for Industry Leaders to Navigate Regulatory Complexities Enhance Innovation and Drive Sustainable Market Development

To capitalize on emerging opportunities and navigate the evolving regulatory and competitive landscape, industry leaders should pursue several actionable strategies. First, prioritizing modular platform designs that accommodate multiple material compositions and drug-eluting profiles will enhance flexibility and accelerate product iterations. By segmenting portfolios to address specific lesion types and patient subgroups, organizations can differentiate offerings and optimize clinical outcomes.

Second, forging collaborative networks with leading academic centers and interventional cardiology societies will facilitate rapid clinical validation and broader consensus on best practices. Early engagement in post-market registries and real-world evidence initiatives will strengthen the value narrative for payers and providers. Furthermore, aligning value propositions with outcome-based contracting can unlock new reimbursement pathways and foster shared-risk models.

Third, strengthening supply chain agility through dual sourcing strategies and domestic manufacturing partnerships will mitigate the impact of geopolitical disruptions and tariff fluctuations. Concurrently, investing in digital supply chain platforms will enhance visibility and traceability, thereby optimizing inventory management and reducing time-to-market.

Lastly, embracing digital integration in both clinical and post-procedure settings-through remote monitoring, predictive analytics, and telemedicine-will elevate the standard of care and support differentiated product offerings. By implementing these targeted recommendations, stakeholders can advance sustainable growth and cement their leadership in the biodegradable coronary stent domain.

Detailing Robust Research Methodology and Analytical Framework Ensuring Credibility Transparency and Rigorous Examination of Biodegradable Coronary Stent Dynamics

A rigorous research methodology underpins the insights presented in this report, combining both qualitative and quantitative analytical frameworks to ensure comprehensive coverage. The process began with an extensive review of peer-reviewed journals, regulatory filings, and clinical trial databases to assemble a robust evidence base on device performance, safety outcomes, and material science developments.

Primary research included in-depth interviews with interventional cardiologists, hospital procurement professionals, and device development specialists. These interviews provided nuanced perspectives on clinical adoption barriers, procurement decision-making processes, and end-user training requirements. Complementing these insights, secondary sources such as healthcare policy documents, tariff legislation texts, and published conference proceedings were systematically analyzed.

Data triangulation was achieved through cross-validation of interview findings with publicly available performance metrics and product registries. Economic and supply chain analyses were conducted using proprietary cost modeling tools, incorporating variables such as material pricing fluctuations, manufacturing overheads, and distribution channel efficiencies. Regional segmentation was validated through country-level healthcare infrastructure assessments and reimbursement policy reviews.

Collectively, this multi-method approach delivers a balanced, transparent, and rigorous examination of the biodegradable coronary stent landscape, equipping stakeholders with the actionable intelligence needed to inform strategic planning and investment decisions.

Concluding Strategic Imperatives Emphasizing Integration of Technological Advancements Collaborative Ecosystems and Patient Centric Approaches for Future Success

The evolution of biodegradable coronary stents reflects a broader shift toward patient-centric, minimally invasive cardiovascular therapies. Technological advancements in materials, coupled with digital integration and streamlined regulatory pathways, have accelerated the introduction of scaffolds that address both short-term procedural efficacy and long-term vessel healing. At the same time, tariff considerations and regional nuances underscore the importance of adaptive supply chain and pricing strategies.

Segmentation insights demonstrate that material innovation, clinical application differentiation, and end-user preferences are critical drivers of competitive positioning. Regional analysis highlights varied adoption trajectories, with developed markets focusing on premium product features and emerging territories balancing access with cost considerations. Industry leaders are responding through strategic alliances, clinical evidence generation, and targeted investments in manufacturing resilience.

Moving forward, stakeholder collaboration across research institutions, clinical centers, and regulatory agencies will be essential to sustain momentum. By aligning value propositions with real-world outcomes and integrating digital tools for remote monitoring, companies can further enhance the safety and efficacy narratives of bioresorbable scaffolds.

Ultimately, the future success of biodegradable coronary stents will hinge on the ability to harmonize technological innovation, operational agility, and value-driven partnerships to deliver meaningful improvements in cardiovascular care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Material
    • Iron
    • Magnesium
    • Polymer
      • Pdlla
      • Plla
  • Application
    • Acute Coronary Syndrome
    • Stable Angina
  • End User
    • Ambulatory Surgical Centers
      • Hospital-Owned Ambulatory Surgical Centers
      • Independent Ambulatory Surgical Centers
    • Hospitals
      • Cardiac Centers
      • Multi-Specialty Hospitals
  • Distribution Channel
    • Direct Tender
    • Third Party Distributor
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Elixir Medical Corporation
  • Reva Medical, Inc.
  • Xeltis AG
  • OrbusNeich Medical Company

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of novel magnesium alloy technologies to enhance resorption rates in coronary stents
5.2. Advancements in dual drug elution coatings optimizing antithrombotic performance in bioresorbable stents
5.3. Emergence of personalized bioresorbable scaffold designs tailored to patient-specific vessel geometries
5.4. Influence of evolving FDA and CE regulatory guidelines on clinical trial designs for biodegradable stents
5.5. Cost-effectiveness analysis driving procurement decisions in public health systems for bioresorbable scaffolds
5.6. Collaborations between device manufacturers and imaging technology firms to improve scaffold deployment accuracy
5.7. Longitudinal safety data demonstrating reduced late stent thrombosis with next-generation resorbable platforms
5.8. Supply chain integration of eco-friendly manufacturing processes for biodegradable cardiovascular implants
5.9. Market penetration strategies targeting emerging Asia-Pacific regions with rising prevalence of coronary artery disease
5.10. Impact of physician training programs on procedural success rates for bioresorbable coronary stent implantation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Coronary Stents Market, by Material
8.1. Introduction
8.2. Iron
8.3. Magnesium
8.4. Polymer
8.4.1. Pdlla
8.4.2. Plla
9. Biodegradable Coronary Stents Market, by Application
9.1. Introduction
9.2. Acute Coronary Syndrome
9.3. Stable Angina
10. Biodegradable Coronary Stents Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Hospital-Owned Ambulatory Surgical Centers
10.2.2. Independent Ambulatory Surgical Centers
10.3. Hospitals
10.3.1. Cardiac Centers
10.3.2. Multi-Specialty Hospitals
11. Biodegradable Coronary Stents Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Third Party Distributor
12. Americas Biodegradable Coronary Stents Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biodegradable Coronary Stents Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biodegradable Coronary Stents Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. Boston Scientific Corporation
15.3.3. Biotronik SE & Co. KG
15.3.4. Terumo Corporation
15.3.5. Lepu Medical Technology (Beijing) Co., Ltd.
15.3.6. Meril Life Sciences Pvt. Ltd.
15.3.7. Elixir Medical Corporation
15.3.8. Reva Medical, Inc.
15.3.9. Xeltis AG
15.3.10. OrbusNeich Medical Company
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE CORONARY STENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIODEGRADABLE CORONARY STENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIODEGRADABLE CORONARY STENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIODEGRADABLE CORONARY STENTS MARKET: RESEARCHAI
FIGURE 24. BIODEGRADABLE CORONARY STENTS MARKET: RESEARCHSTATISTICS
FIGURE 25. BIODEGRADABLE CORONARY STENTS MARKET: RESEARCHCONTACTS
FIGURE 26. BIODEGRADABLE CORONARY STENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIODEGRADABLE CORONARY STENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY IRON, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY IRON, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MAGNESIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MAGNESIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY PDLLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY PDLLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY PLLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY PLLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITAL-OWNED AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITAL-OWNED AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY INDEPENDENT AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY INDEPENDENT AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MULTI-SPECIALTY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MULTI-SPECIALTY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 86. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 87. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 88. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 89. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 94. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 95. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 100. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 103. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 172. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 173. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 174. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 175. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 186. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 187. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 188. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 189. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 214. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 215. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 216. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 217. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 222. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 223. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 224. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 225. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 228. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 229. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 230. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 231. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 284. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 285. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 286. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 287. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 292. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 293. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY POLYMER, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS BIODEGRADABLE CORONARY STENTS MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biodegradable Coronary Stents market report include:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Elixir Medical Corporation
  • Reva Medical, Inc.
  • Xeltis AG
  • OrbusNeich Medical Company